Affibody-mediated transferrin depletion for proteomics applications
2007 (English)In: Biotechnology Journal, ISSN 1860-6768, Vol. 2, no 11, 1389-1398 p.Article in journal (Refereed) Published
An Affibody® (Affibody) ligand with specific binding to human transferrin was selected by phage display technology from a combinatorial protein library based on the staphylococcal protein A (SpA)-derived Z domain. Strong and selective binding of the selected Affibody ligand to transferrin was demonstrated using biosensor technology and dot blot analysis. Impressive specificity was demonstrated as transferrin was the only protein recovered by affinity chromatography from human plasma. Efficient Affibody-mediated capture of transferrin, combined with IgG- and HSA-depletion, was demonstrated for human plasma and cerebrospinal fluid (CSF). For plasma, 85% of the total transferrin content in the samples was depleted after only two cycles of transferrin removal, and for CSF, 78% efficiency was obtained in single-step depletion. These results clearly suggest a potential for the development of Affibody-based resins for the removal of abundant proteins in proteomics analyses.
Place, publisher, year, edition, pages
2007. Vol. 2, no 11, 1389-1398 p.
Affibody ligand; Affinity resin; Protein engineering; Proteomics; Transferrin
Industrial Biotechnology Natural Sciences
IdentifiersURN: urn:nbn:se:uu:diva-172142DOI: 10.1002/biot.200700053OAI: oai:DiVA.org:uu-172142DiVA: diva2:513428